Welcome to Paid Research Studies




  • Conditions:   Acute Lymphoblastic Leukemia;   Hyperbilirubinemia
    Interventions:   Dietary Supplement: Levocarnitine;   Drug: Vitamin B Complex
    Sponsors:   M.D. Anderson Cancer Center;   National Cancer Institute (NCI)
    Recruiting

  • Conditions:   NK-Cell Lymphoma;   NK-Cell Leukemia;   Peripheral T Cell Lymphoma
    Interventions:   Drug: Methotrexate;   Drug: pralatraxate,;   Drug: Ifosfamide;   Drug: Dexamethasone;   Drug: Etoposide;   Drug: Pegaspargase;   Drug: cyclophosphamide;   Drug: Doxorubicin;   Drug: Prednisone;   Drug: Brentuximab Vedotin
    Sponsors:   New York Medical College;   University of Alabama at Birmingham
    Recruiting

  • Condition:   B-cell Acute Lymphoblastic Leukemia
    Interventions:   Drug: Inotuzumab ozogamicin;   Drug: Prednisone Pill;   Drug: Daunorubicin;   Drug: Vincristine;   Drug: Cytarabine;   Drug: Methotrexate;   Drug: Pegaspargase
    Sponsors:   University of Virginia;   Pfizer;   Vanderbilt University;   University of Wisconsin, Madison;   Virginia Commonwealth University
    Not yet recruiting

  • Conditions:   Refractory Acute Lymphoblastic Leukemia;   Relapsed Acute Lymphoblastic Leukemia
    Interventions:   Drug: Pevonedistat;   Drug: Vincristine;   Drug: Dexamethasone;   Drug: PEG-asparaginase;   Drug: Doxorubicin;   Drug: Cytarabine;   Drug: Methotrexate;   Drug: Hydrocortisone
    Sponsors:   Julio Barredo;   Takeda
    Recruiting

  • Conditions:   Acute Lymphoblastic Leukemia;   Acute Lymphoblastic Lymphoma
    Interventions:   Drug: Prednisone;   Drug: Vincristine;   Drug: Daunorubicin;   Drug: Pegaspargase;   Drug: Erwinase®;   Drug: Rituximab;   Drug: Cyclophosphamide;   Drug: Cytarabine;   Drug: Mercaptopurine;   Drug: Dasatinib;   Drug: Methotrexate;   Drug: Blinatumomab;   Drug: Ruxolitinib;   Drug: Bortezomib;   Drug: Dexamethasone;   Drug: Doxorubicin;   Drug: Etoposide;   Drug: Clofarabine;   Drug: Vorinostat;   Drug: Idarubicin;   Drug: Nelarabine
    Sponsors:   St. Jude Children's Research Hospital;   Bristol-Myers Squibb;   Incyte Corporation;   Shire
    Recruiting

  • Conditions:   Recurrent B Acute Lymphoblastic Leukemia;   Recurrent T Acute Lymphoblastic Leukemia;   Refractory B Acute Lymphoblastic Leukemia;   Refractory T Acute Lymphoblastic Leukemia
    Interventions:   Drug: Cyclophosphamide;   Drug: Cytarabine;   Drug: Dexamethasone;   Drug: Methotrexate;   Drug: Nelarabine;   Drug: Pegaspargase;   Drug: Prednisone;   Biological: Rituximab;   Drug: Venetoclax;   Drug: Vincristine
    Sponsors:   M.D. Anderson Cancer Center;   National Cancer Institute (NCI)
    Recruiting

  • Conditions:   T Acute Lymphoblastic Leukemia;   T Lymphoblastic Lymphoma
    Interventions:   Drug: Cyclophosphamide;   Drug: Cytarabine;   Drug: Dexamethasone;   Drug: Doxorubicin Hydrochloride;   Drug: Mercaptopurine;   Drug: Methotrexate;   Drug: Nelarabine;   Drug: Pegaspargase;   Drug: Prednisone;   Drug: Venetoclax;   Drug: Vincristine Sulfate
    Sponsors:   M.D. Anderson Cancer Center;   National Cancer Institute (NCI)
    Recruiting

  • Conditions:   Acute Lymphoblastic Leukemia;   ALL, Childhood;   ALL
    Interventions:   Drug: Ruxolitinib;   Drug: Cyclophosphamide;   Drug: Cytarabine;   Drug: Mercaptopurine;   Drug: Vincristine;   Drug: Pegaspargase;   Drug: Rituximab;   Drug: Methotrexate (Intrathecal Administration);   Drug: Methotrexate (Intravenous Administration);   Drug: Dexamethasone;   Drug: Doxorubicin;   Drug: Thioguanine;   Drug: Methotrexate Oral Product
    Sponsors:   University of Chicago;   Incyte Corporation
    Not yet recruiting

  • Condition:   Acute Lymphoblastic Leukemia
    Interventions:   Drug: ITMHA;   Drug: Dexamethasone;   Drug: Mitoxantrone;   Drug: Pegaspargase;   Drug: Asparaginase Erwinia Chrysanthemi;   Drug: Bortezomib;   Drug: Vorinostat;   Drug: Cyclophosphamide;   Drug: Mercaptopurine;   Drug: Methotrexate;   Drug: Leucovorin Calcium;   Drug: Cytarabine;   Drug: Etoposide;   Drug: Vincristine
    Sponsors:   St. Jude Children's Research Hospital;   Gateway for Cancer Research;   Texas Children's Hospital
    Recruiting

  • Condition:   Leukemia
    Interventions:   Drug: Daunorubicin;   Drug: Vincristine;   Drug: Prednisone;   Drug: PEG-Asparaginase;   Drug: Methotrexate;   Drug: 6-MP (6-Mercaptopurine);   Drug: Cyclophosphamide;   Drug: Cytarabine;   Drug: Leucovorin;   Drug: Dexamethasone;   Other: Blood draw;   Device: CT/PET scans
    Sponsors:   Memorial Sloan Kettering Cancer Center;   Shire;   Duke University;   Weill Medical College of Cornell University;   Lehigh Valley Health Network
    Recruiting

  • Condition:   Acute Lymphoblastic Leukemia, Pediatric
    Interventions:   Drug: Pegaspargase;   Drug: Erwinia asparaginase;   Drug: Cyclophosphamide;   Drug: CYTARABINE;   Drug: DASATINIB;   Drug: DEXAMETHASONE;   Drug: Dexrazoxane;   Drug: Doxorubicin;   Drug: ETOPOSIDE;   Drug: HYDROCORTISONE;   Drug: LEUCOVORIN CALCIUM;   Drug: MERCAPTOPURINE;   Drug: METHOTREXATE;   Drug: NELARABINE;   Drug: Vincristine
    Sponsors:   Dana-Farber Cancer Institute;   Servier
    Recruiting

  • Conditions:   Leukemia, Lymphocytic;   Lymphoblastic Lymphoma;   T-cell Lymphoma;   T-cell Leukemia;   Recurrent Disease;   Acute Leukemia
    Interventions:   Drug: Palbociclib;   Drug: Cytarabine;   Drug: Methotrexate;   Drug: Hydrocortisone;   Drug: Doxorubicin;   Drug: Prednisolone;   Drug: Vincristine;   Drug: Pegaspargase
    Sponsor:   Children's Oncology Group
    Recruiting

  • Condition:   Acute Lymphoblastic Leukemia (ALL)
    Interventions:   Drug: Carfilzomib;   Drug: Dexamethasone;   Drug: Mitoxantrone;   Drug: PEG-asparaginase;   Drug: Vincristine;   Drug: Intrathecal (IT) Methotrexate;   Drug: Intrathecal Triple Therapy (Intrathecal Cytarabine, Hydrocortisone, and Methotrexate);   Drug: 6-Mercaptopurine;   Drug: Cyclophosphamide;   Drug: Cytarabine;   Drug: Daunorubicin
    Sponsors:   Amgen;   Therapeutic Advances in Childhood Leukemia & Lymphoma (TACL) - Study Design & Execution Collaborator;   Innovative Therapies For Children with Cancer Consortium
    Recruiting

  • Condition:   Precursor Cell Lymphoblastic Leukemia-Lymphoma
    Interventions:   Drug: Daratumumab;   Drug: Vincristine;   Drug: Prednisone;   Drug: Doxorubicin;   Biological: Peg-asparaginase;   Drug: Cyclophosphamide;   Drug: Cytarabine;   Drug: 6-mercaptopurine;   Drug: Methotrexate
    Sponsor:   Janssen Research & Development, LLC
    Recruiting

  • Conditions:   Acute Lymphoblastic Leukemia (ALL);   Lymphoblastic Lymphoma
    Interventions:   Drug: Navitoclax;   Drug: Chemotherapy;   Drug: Venetoclax
    Sponsor:   AbbVie
    Recruiting

  • Conditions:   B Acute Lymphoblastic Leukemia;   BCR-ABL1 Fusion Protein Expression;   Minimal Residual Disease;   Philadelphia Chromosome Positive;   T Acute Lymphoblastic Leukemia;   Untreated Adult Acute Lymphoblastic Leukemia;   Untreated Childhood Acute Lymphoblastic Leukemia
    Interventions:   Procedure: Allogeneic Hematopoietic Stem Cell Transplantation;   Drug: Cyclophosphamide;   Drug: Cytarabine;   Drug: Daunorubicin Hydrochloride;   Drug: Dexamethasone;   Drug: Dexrazoxane Hydrochloride;   Drug: Doxorubicin;   Drug: Etoposide;   Biological: Filgrastim;   Drug: Ifosfamide;   Drug: Imatinib Mesylate;   Other: Laboratory Biomarker Analysis;   Drug: Leucovorin Calcium;   Drug: Mercaptopurine;   Drug: Methotrexate;   Drug: Methylprednisolone;   Drug: Pegaspargase;   Drug: Prednisolone;   Other: Questionnaire Administration;   Drug: Therapeutic Hydrocortisone;   Drug: Thioguanine;   Drug: Vincristine Sulfate
    Sponsors:   Children's Oncology Group;   National Cancer Institute (NCI);   University of Milano Bicocca
    Recruiting

  • Conditions:   Acute Leukemia of Ambiguous Lineage;   B Acute Lymphoblastic Leukemia;   KMT2A Gene Rearrangement;   Mixed Phenotype Acute Leukemia
    Interventions:   Drug: Azacitidine;   Drug: Cyclophosphamide;   Drug: Cytarabine;   Drug: Daunorubicin Hydrochloride;   Drug: Dexamethasone;   Drug: Hydrocortisone Sodium Succinate;   Other: Laboratory Biomarker Analysis;   Drug: Leucovorin Calcium;   Drug: Mercaptopurine;   Drug: Methotrexate;   Drug: Pegaspargase;   Other: Pharmacological Study;   Drug: Prednisolone;   Drug: Thioguanine;   Drug: Vincristine Sulfate
    Sponsor:   National Cancer Institute (NCI)
    Recruiting

  • Condition:   B Acute Lymphoblastic Leukemia
    Interventions:   Procedure: Allogeneic Hematopoietic Stem Cell Transplantation;   Drug: Asparaginase;   Biological: Blinatumomab;   Drug: Cyclophosphamide;   Drug: Cytarabine;   Drug: Dexamethasone;   Drug: Etoposide;   Other: Laboratory Biomarker Analysis;   Drug: Leucovorin Calcium;   Drug: Mercaptopurine;   Drug: Methotrexate;   Drug: Mitoxantrone Hydrochloride;   Drug: Pegaspargase;   Other: Pharmacological Study;   Drug: Therapeutic Hydrocortisone;   Drug: Thioguanine;   Drug: Vincristine Sulfate
    Sponsor:   National Cancer Institute (NCI)
    Recruiting

  • Conditions:   Acute Lymphoblastic Leukemia;   B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative;   BCR/ABL1 Fusion Protein Negative;   Untreated Adult Acute Lymphoblastic Leukemia
    Interventions:   Procedure: Allogeneic Hematopoietic Stem Cell Transplantation;   Biological: Blinatumomab;   Drug: Cyclophosphamide;   Drug: Cytarabine;   Drug: Daunorubicin Hydrochloride;   Drug: Dexamethasone;   Drug: Etoposide;   Other: Laboratory Biomarker Analysis;   Drug: Mercaptopurine;   Drug: Methotrexate;   Drug: Pegaspargase;   Drug: Prednisone;   Biological: Rituximab;   Drug: Vincristine Sulfate
    Sponsors:   National Cancer Institute (NCI);   Canadian Cancer Trials Group
    Recruiting

  • Conditions:   ALL, Childhood;   Lymphoblastic Lymphoma, Childhood;   Lymphoblastic Leukemia, Acute, Childhood
    Interventions:   Drug: Ixazomib;   Drug: Vincristine;   Drug: Dexamethasone;   Drug: Asparaginase;   Drug: Doxorubicin
    Sponsors:   Therapeutic Advances in Childhood Leukemia Consortium;   Takeda;   Children's Hospital Los Angeles
    Recruiting

  • Condition:   Leukemia
    Interventions:   Drug: Ruxolitinib;   Drug: Asparaginase Erwinia Chrysanthemi;   Drug: Cyclophosphamide;   Drug: Cytarabine;   Drug: Dexamethasone;   Drug: Doxorubicin;   Drug: Leucovorin Calcium;   Drug: Mercaptopurine;   Drug: Methotrexate;   Drug: Pegaspargase;   Drug: Prednisone;   Drug: Thioguanine;   Drug: Vincristine Sulfate
    Sponsors:   Incyte Corporation;   Children's Oncology Group
    Recruiting

  • Condition:   Leukemia
    Interventions:   Biological: anti-thymocyte globulin;   Drug: asparaginase;   Drug: busulfan;   Drug: cyclophosphamide;   Drug: cyclosporine;   Drug: cytarabine;   Drug: daunorubicin hydrochloride;   Drug: etoposide;   Drug: leucovorin calcium;   Drug: melphalan;   Drug: mercaptopurine;   Drug: methotrexate;   Drug: mitoxantrone hydrochloride;   Drug: pegaspargase;   Drug: prednisolone;   Drug: prednisone;   Drug: therapeutic hydrocortisone;   Drug: thioguanine;   Drug: vincristine sulfate;   Procedure: allogeneic bone marrow transplantation;   Procedure: allogeneic hematopoietic stem cell transplantation;   Procedure: umbilical cord blood transplantation
    Sponsors:   Dutch Childhood Oncology Group;   BFM Germany;   CORS Monza Italy;   Associazione Italiana Ematologia Oncologia Pediatrica;   Australian and New Zealand Children's Oncology Group;   BFM Austria;   CLCG France Belgium Portugal;   COALL Germany;   CPH, Czech republic;   DFCI consortium USA;   FRALLE France;   Hong Kong;   MD Anderson USA;   NOPHO Scandinavian countries;   PINDA, Chile;   PPLLSG Poland;   Seattle USA;   SJCRH USA;   UKCCSG United Kingdom
    Recruiting

  • Condition:   B Acute Lymphoblastic Leukemia
    Interventions:   Drug: Allopurinol;   Drug: Cytarabine;   Drug: Daunorubicin Hydrochloride;   Drug: Vincristine Sulfate;   Drug: Dexamethasone;   Drug: Pegylated L-Asparaginase;   Drug: Methotrexate;   Procedure: Bone Marrow Aspiration and Biopsy;   Drug: Cyclophosphamide;   Drug: Mercaptopurine;   Biological: Rituximab;   Drug: Doxorubicin;   Drug: Thioguanine;   Biological: Inotuzumab Ozogamicin;   Other: Laboratory Biomarker Analysis
    Sponsors:   Alliance for Clinical Trials in Oncology;   National Cancer Institute (NCI)
    Recruiting

  • Conditions:   Malignancies;   Acute Lymphoblastic Leukemia (ALL);   Acute Myeloid Leukemia (AML);   Non-Hodgkin's Lymphoma;   Neuroblastoma
    Interventions:   Drug: chemotherapy;   Drug: venetoclax
    Sponsors:   AbbVie;   Roche-Genentech
    Recruiting

  • Conditions:   ALL, Childhood;   Lymphoblastic Leukemia, Acute, Childhood;   Lymphoblastic Leukemia, Acute
    Intervention:   Drug: Marqibo
    Sponsors:   Therapeutic Advances in Childhood Leukemia Consortium;   Spectrum Pharmaceuticals, Inc
    Recruiting